Fresh Tracks Therapeutics...

NASDAQ: FRTX · Real-Time Price · USD
0.94
0.00 (0.00%)
At close: Feb 28, 2025, 12:19 PM

Fresh Tracks Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
8.01M 6.94M 404K
Cost of Revenue
n/a 14.04M 28.23M
Gross Profit
8.01M -7.1M -27.83M
Operating Income
-6.36M -21.53M -40.24M
Interest Income
n/a 9K 69K
Pretax Income
-5.69M -21.1M -39.47M
Net Income
-5.69M -20.66M -39.52M
Selling & General & Admin
11.18M 14.43M 12.42M
Research & Development
3.18M 14.04M 28.23M
Other Expenses
n/a 441K 839K
Operating Expenses
14.37M 28.48M 40.65M
Interest Expense
5K 9K 69K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
14.37M 28.48M 40.65M
Income Tax Expense
n/a -441K 47K
Shares Outstanding (Basic)
5.91M 2.81M 1.78M
Shares Outstanding (Diluted)
5.91M 2.81M 1.78M
EPS (Basic)
-0.96 -7.36 -22.14
EPS (Diluted)
-0.96 -7.36 -22.14
EBITDA
-5.65M -21.06M -39.38M
EBIT
-5.69M -21.09M -39.41M
Depreciation & Amortization
41K 30K 22K